ctrl K

Watchlist Price Alert

Drugs Made In America Acq... (DMAA)

NASDAQ: DMAA · Real-Time Price · USD

10.09

-0.01 (-0.10%)

At close: May 07, 2025, 11:32 AM

Drugs Made In America Acquisition Ordinary Shares Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024
Period Ending	Dec 31, 2024
Cash & Equivalents	1.35
Short-Term Investments	1.35K
Long-Term Investments	n/a
Other Long-Term Assets	545.83
Receivables	n/a
Inventory	n/a
Other Current Assets	n/a
Total Current Assets	4.99K
Property-Plant & Equipment	n/a
Goodwill & Intangibles	n/a
Total Long-Term Assets	545.83
Total Assets	550.82
Account Payables	n/a
Deferred Revenue	n/a
Short-Term Debt	662.32
Other Current Liabilities	56.06
Total Current Liabilities	795.67
Long-Term Debt	n/a
Other Long-Term Liabilities	n/a
Total Long-Term Liabilities	n/a
Total Liabilities	795.67
Total Debt	662.32
Common Stock	986.00
Retained Earnings	-279.85
Comprehensive Income	n/a
Shareholders Equity	-244.84
Total Investments	1.35K